Amine Metabolism in Brain
This paper attempts to provide a background of experimental studies mainly in animals but some in man, against which it may be possible to examine more clearly some of the reports of disturbances in cerebral amine metabolism in psychiatric illness.
Distribution ofthe Amines in Brain
The gross distribution of the amines in brain has been examined in a series of studies using biological or fluorescence assay methods. These studies have been recently reviewed by Adam (1969) .
At the cellular level Swedish workers have developed the technique of fluorescence microscopy for the identification of 5-hydroxytryptamine (5-HT), noradrenaline (NA) and dopamine (DA) containing neurones and fibre tracts in brain and spinal cord (Fuxe et al. 1969) . Cerebral Metabolism in the Amines Certain features of amine metabolism have been selected for comment as they appear to have particular relevance to the discussion of amines in relation to psychiatry.
The Indolalkylamines (Fig 1) (1) The uptake of tryptophan into brain is an active process allowing the amino acid to cross the blood-brain barrier whilst the amine 5-HT does not readily penetrate the barrier.
(2) Tryptamine cannot be detected in animal brain under normal circumstances nor after tryptophan administration. A small amount appears when monoamine oxidase inhibitors (MA0Is) are given prior to tryptophan administration (Eccleston, Ashcroft, Crawford & Loose 1966) .
(3) Tryptophan administration in animals results in a rise in brain levels of 5-HT and its metabolite 5-hydroxyindol-3ylacetic acid (5-HIAA) but only at those sites which normally contain the amine. 5-hydroxytryptophan (5-HTP) given in low dosage (comparable to the dose used in human clinical studies) produces no increase in brain levels of 5-HT being metabolized to 5-HIAA (Moir & Eccleston 1968) . Thus it appears that tryptophan administration is the method of choice for the stimulation of 5-HT metabolism in brain, a finding which would be consistent with its reported success in the treatment of depressive illness (Coppen et al. 1967 ).
(4) The main metabolite of 5-HT in brain is 5-HIAA although it is possible that in some circumstances 5-hydroxytryptophol may be produced (Eccleston, Moir, Reading & Ritchie 1966 ). (5) 5-HIAA is actively transported from cerebrospinal fluid (CSF) to blood and possibly from brain tissue to blood (Guldberg et al. 1966 , Neff et al. 1964 ).
Cerebral Metabolism ofNoradrenaline and Dopamine (Fig 2) (1) Whilst 3-methoxy-4-hydroxy mandelic acid (VMA) is the major metabolite formed from noradrenaline outside the brain, within the brain little VMA is formed and the glycols, in particular 3-methoxy-4-hydroxy phenylglycol, comprise the main metabolic products (Schanberg et al. 1968 ).
(2) For dopamine the acids homovanillic acid (HVA) and dihydroxyphenylacetic acid are the main metabolites in brain as in other tissues.
(3) In brain as in the periphery three mechanisms seemed to be involved in the inactivation of released NA, the enzymes monoamine oxidase and catechol-O-methyl transferase and also the process of active re-uptake into nerve terminals. 60 Functions ofthe Amines in Brain The amines in brain have been linked with the regulation of mood, autonomic functions, sleep and temperature control. The mode of action of the amines at cellular level has received considerable attention. The histochemical studies of the Swedish workers have shown the anines to be concentrated in axonal varicosities, ideally situated to function as synaptic transmitters. Release of amines on stimulation of neurones in brain would provide further evidence for such a transmitter function. In Edinburgh, Eccleston, Randic, Roberts & Straughan '(1568) have recently demonstrated the release of 5-HT into cups placed on the cerebral cortex following stimulation of the mid-brain raphe nuclei in nialamide pretreated cats.
Investigation ofCerebral Metabolism in Living Animals andMan
Routes of access to the study of cerebral metabolism in man are-strictly limited. We chose to examine the possibility that the levels of amine metabolites in CSF might reflect the cerebral metabolism ofthe amines.
In an early study Ashcroft & Sharman (1960) showed that the concentration of 5-HIAA was low in the lumbar CSF of patients complaining of depression. In the same study it was also shown that in man levels of the metabolite are much higher in ventricular than in lumbar fluid. Subsequent work within the MRC Unit in Edinburgh has been devoted to the examination of the following questions:
(1) Do CSF metabolite levels reflect cerebral metabolism?
(2) What is the reason for the gradient in metabolite levels between ventricular and lumbar CSF?
CSF Studies in Animals
We have attempted in dogs to examine the way in which concentrations of 5-HIAA and HVA in cisteral and lateral ventricular CSF reflect the levels of the metabolites in specific brain areas.
These studies have demonstrated that levels of 5-HLAA and HVA in lateral ventricular CSF reflect changes in adjoining brain areas, e.g. caudate nucleus (Guldberg & Yates 1968 ), whilst cisternal, and probably also lumbar, fluid levels of 5-HIAA reflect levels of the metabolite in the brain stem, in particular the hindbrain (Eccleston, Ashcroft, Moir, Parker-Rhodes, Lutz & O'Mahoney 1968).
The gradient of metabolite levels from lateral ventricle to cisterna can be explained by the presence of an active transport mechanism in the region of the IV ventricle (probably in the choroid plexus) transporting the acids fronm CSF to the blood (Guldberg et al. 1966 , Ashcroft, Dow & Moir 1968 ). Thus in the interpretation of changes in lumbar CSF metabolite concentrations in man two major sources of variation should be considered: (1) A change in the cerebral release or metabolism of the parent amine. (2) A change in the efficiency of the transport of metabolites or in the mixing of CSF.
Lumbar CSFStudies in DepressedPatients
Following our early report (Ashcroft & Sharman 1960) information necessary to interpret the findings. In 1966 we reported a more detailed investigation in which an attempt was made to standardize conditions of CSF sampling, drug administration and activity of the patients prior to sampling (Ashcroft et al. 1966) . We reported confirmation of the 1960 findings in depression and in addition it was possible to show that the reduction of 5-HIAA levels appeared to be related to the severity of the depression and that levels rose with remission of symptoms. Further confirmation was provided by Dencker et al. (1966) who also measured HVA levels in some patients showing low levels of 5-HIAA but normal HVA levels. These latter findings rather argue against any disorder of transport of the acids which would be expected to affect both acids. It thus appears that there may be a failure of metabolic formation or functional release of 5-HT in depressed patients.
Relevance ofthese Findings to Clinical Psychiatry
It is dangerous to resort to oversimplification in the interpretation of the findings. For example, even if it is further confirmed that levels of 5-HIAA are low in the CSF and brains (Bourne et al. 1968) of depressed people this does not mean that there is necessarily a primary biochemical lesion. Low metabolite concentration might represent either the result of a metabolic fault or a failure in the functional release of the parent amine, i.e. they might have either a cause or effect relationship with depression. It is not enough, therefore, to show that depressed people have low 5-HIAA levels in CSF, we must go on to ask a series of subsidiary questions: (1) How can we distinguish the patients with a fault in metabolism, e.g. in the cerebral hydroxylation of tryptophan, from those with a failure in the functional release of the amine? (2) Can the biochemical findings be correlated with the clinical syndromes and can they help in some patients in the design of specific therapies ?
These are questions for the future but one promising approach to the search for a defect in 5-hydroxyindole metabolism in the brain may be provided by CSF studies of 5-HIAA levels after tryptophan administration.
